Reuters: Regulatory News: BRIEF-Prezista receives European commission approval for HIV-1 infection

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

BRIEF-Prezista receives European commission approval for HIV-1 infection Oct 25th 2012, 13:49 LONDON | Thu Oct 25, 2012 9:49am EDT LONDON Oct 25 (Reuters) - Janssen-Cilag International * Prezista(R)(darunavir) oral suspension receives European commission approval

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions